NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That’s Changing Everything
Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is changing rapidly. In this Industry…
S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis
In this episode of Lipid Insights, we explore the NLA’s recent expert meta-analysis, “Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in…
Industry Innovations | Episode 4: Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion
In this compelling episode of NLA Industry Innovations, guest host Kevin Maki, PhD, CLS, MNLA sits down with renowned lipidologist and clinical researcher Michael H. Davidson, MD, FACC,…
S6E9: Beef and Cardiovascular Disease: What the Science Says
In this episode of Lipid Insights, Dr. Peter Jones and guest Dr. Kevin Maki explore whether beef deserves its long-standing reputation as a driver of cardiovascular disease. Drawing on…
S5E4: Role of Apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults
Listen to Dr. Brown discuss with Dr. Saseen and Dr. Maki about the role of apolipoprotein B in the clinical management of cardiovascular risk in…
Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults: An Expert Clinical Consensus from the National Lipid Association
ApoB represents the total concentration of atherogenic lipoprotein particles in the circulation and more accurately reflects the atherogenic burden of lipoproteins when compared to low-density…
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association
This joint expert review provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.
The Lipid Panel – Non-alcoholic Fatty Liver Disease
